The Govt. of India have created a separate, dedicated, autonomous institution in the form of the Indian Pharmacopoeia Commission (IPC) to deal with matters relating to timely publication of the Indian Pharmacopoeia which is the official book of standards for drug included therein, in terms of the Second Schedule to the Drugs and Cosmetics Act, 1940 so as to specify the standards of identify, purity and strength of the drugs imported, manufactured for sale, stocked or exhibited for sale or distributed in India. The mandate of the Commission is to perform, inter-alia, functions such as revision and publication of the Indian Pharmacopoeia and National formulary of India on a regular basis besides providing IP Reference Substances and training to the stakeholders on Pharmacopoeial issues. The Commission has become fully operational from 1st January, 2009 as an Autonomous Body, fully financed by the Central Government with specific budgetary allocations under administrative control of the Ministry of Health and Family Welfare.
Application are invited for In-Person Brainstorming Session on “Building a Comprehensive Ecosystem for Patient Safety: Ensuring Quality of Medicines, Medical Devices and Blood Products in India”
Brainstorming Session
on Building a Comprehensive Ecosystem for Patient Safety Ensuring Quality of Medicines, Medical Devices, and Blood Products in India
Organised by
Indian Pharmacopoeia Commission (MoH&FW)
in collaboration
with Yashoda Medicity, Indirapuram, Ghaziabad
Registration Fee : NIL
Mode : In-person (Physical only)
Who can attend?
• Senior-Level Hospital Representatives
• Clinicians / Medical Practitioner
• Quality Managers
• Healthcare Administrators
Registration Deadline : 30th June 2026
Date : 7th July 2026, Tuesday
Time : 10:30 am - 01:30 pm
Venue : Yashoda Medicity,
Indirapuram, Ghaziabad
